Stocktoria
BioCardia, Inc. BCDA
BioCardia, Inc. financials (annual)
Bars are annual figures from 2018 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2023 | FY2022 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $58,000 | $477,000 | — | $1.4M | — | $1.0M | $145,000 | $710,000 | $625,000 |
| R&D expense | $5.0M | $4.4M | $7.7M | — | $8.8M | — | $8.6M | $9.8M | $8.6M | $8.5M |
| SG&A expense | $3.3M | $3.7M | $4.4M | — | $4.4M | — | $5.1M | $5.9M | $6.0M | $5.8M |
| Operating income | -$8.3M | -$8.0M | -$11.6M | — | -$11.9M | — | -$12.6M | -$15.5M | -$14.2M | -$14.1M |
| Interest expense | — | — | — | — | — | — | $0 | $3,000 | $112,000 | — |
| Income tax | $0 | $0 | $0 | — | $0 | — | $0 | $0 | $0 | $0 |
| Net income | -$8.2M | -$7.9M | -$11.6M | — | -$11.9M | — | -$12.6M | -$15.0M | -$14.7M | -$14.0M |
| Operating cash flow | -$7.4M | -$7.9M | -$10.0M | — | -$10.6M | — | -$10.4M | -$12.4M | -$9.4M | -$11.1M |
| Free cash flow | -$7.4M | -$7.9M | -$10.0M | — | -$10.6M | — | -$10.5M | -$12.4M | -$9.6M | -$11.1M |
| Cash & equivalents | $2.5M | $2.4M | $1.1M | $4.9M | $7.4M | $6.7M | $12.9M | $21.4M | $5.6M | $5.4M |
| Inventory | — | — | — | — | — | — | — | — | $4,000 | $141,000 |
| Total assets | $3.4M | $3.7M | $3.0M | $7.1M | $9.8M | $12.8M | $15.7M | $23.4M | $7.7M | $6.4M |
| Total liabilities | $2.5M | $2.9M | $4.6M | $5.2M | $4.9M | $5.5M | $5.3M | $4.2M | $5.3M | $2.6M |
| Shareholders' equity | $895,000 | $837,000 | -$1.6M | $1.9M | $4.9M | $7.4M | $10.4M | $19.2M | $2.4M | $3.8M |
Growth · year-over-year
| Metric | FY2025 | FY2024 | FY2023 | FY2023 | FY2022 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | -100.0% | -87.8% | — | — | — | — | +600.0% | -79.6% | +13.6% | +30.5% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.